MediSix Therapeutics

MediSix Therapeutics is a provider of immunology engineering companies that develop novel cell therapies, focusing on addressing T-cell malignancies. Unlike other cell therapy companies, MediSix Therapeutics enhances the anti-cancer activity of their immune cells by generating cells that lack specific surface molecules. In addition to cancer, immune cells targeting T cells could revolutionize the treatment of autoimmune diseases driven by T-cell auto-reactivity.